|
|
| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0003-4040 | Augtyro | repotrectinib | E.R. Squibb & Sons, L.L.C. | CAPSULE | 2023-12-05 | |
| 0003-4160 | Augtyro | repotrectinib | E.R. Squibb & Sons, L.L.C. | CAPSULE | 2024-11-01 |
Loading full table content...